CK Life Sciences Intl (Holdings) Inc
HKEX:775
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.31
0.71
|
Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
Abbvie Inc
NYSE:ABBV
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Realty Income Corp
NYSE:O
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one CK Life Sciences Intl (Holdings) Inc stock under the Base Case scenario is 0.54 HKD. Compared to the current market price of 0.36 HKD, CK Life Sciences Intl (Holdings) Inc is Undervalued by 33%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
CK Life Sciences Intl (Holdings) Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for CK Life Sciences Intl (Holdings) Inc cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Price Target |
Loading
|
Revenue Forecast |
|
Operating Income Forecast |
|
Earnings Forecast |
|
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
CK Life Sciences Intl (Holdings) Inc
Balance Sheet Decomposition
CK Life Sciences Intl (Holdings) Inc
Current Assets | 2.8B |
Cash & Short-Term Investments | 562.1m |
Receivables | 1.1B |
Other Current Assets | 1.2B |
Non-Current Assets | 8.1B |
Long-Term Investments | 1.8B |
PP&E | 2.7B |
Intangibles | 3.5B |
Other Non-Current Assets | 57.1m |
Current Liabilities | 2.9B |
Accounts Payable | 646.7m |
Other Current Liabilities | 2.2B |
Non-Current Liabilities | 4B |
Long-Term Debt | 3.8B |
Other Non-Current Liabilities | 241.4m |
Earnings Waterfall
CK Life Sciences Intl (Holdings) Inc
Revenue
|
5.4B
HKD
|
Cost of Revenue
|
-3.7B
HKD
|
Gross Profit
|
1.6B
HKD
|
Operating Expenses
|
-1.3B
HKD
|
Operating Income
|
324.7m
HKD
|
Other Expenses
|
-343.4m
HKD
|
Net Income
|
-18.7m
HKD
|
Free Cash Flow Analysis
CK Life Sciences Intl (Holdings) Inc
HKD | |
Free Cash Flow | HKD |
Profitability Score
Profitability Due Diligence
CK Life Sciences Intl (Holdings) Inc's profitability score is 44/100. The higher the profitability score, the more profitable the company is.
Score
CK Life Sciences Intl (Holdings) Inc's profitability score is 44/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
CK Life Sciences Intl (Holdings) Inc's solvency score is 41/100. The higher the solvency score, the more solvent the company is.
Score
CK Life Sciences Intl (Holdings) Inc's solvency score is 41/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
CK Life Sciences Intl (Holdings) Inc
Shareholder Yield
Current shareholder yield for CK Life Sciences Intl (Holdings) Inc is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Price
CK Life Sciences Intl (Holdings) Inc
Average Annual Return | 36.4% |
Standard Deviation of Annual Returns | 78.54% |
Max Drawdown | -74% |
Market Capitalization | 3.5B HKD |
Shares Outstanding | 9 611 073 000 |
Percentage of Shares Shorted |
N/A
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
CK Life Sciences International (Holdings), Inc. operates as an investment company, which engages in the business of research and development, manufacturing, commercialization, marketing and selling of products and assets in nutraceuticals, pharmaceuticals and agriculture related business. The company employs 1,855 full-time employees The company went IPO on 2002-07-16. The firm operates through three segments. The Health segment is engaged in the development, production, marketing and sales of healthcare and pharmaceutical products. The healthcare brands under the Company include Lipa, Vitaquest and Sante Naturelle, among others. Its pharmaceutical products include cancer-related pharmaceuticals and painkillers, among others. The Agriculture-related Businesses segment is engaged in the operation of vineyards, as well as the development, production, marketing and sales of agriculture and related products. Its agricultural products include fertilizers and crop protection products, among others. The Investment segment is engaged in the investment in financial and investment products.
Contact
IPO
Employees
Officers
The intrinsic value of one CK Life Sciences Intl (Holdings) Inc stock under the Base Case scenario is 0.54 HKD.
Compared to the current market price of 0.36 HKD, CK Life Sciences Intl (Holdings) Inc is Undervalued by 33%.